Oryon Cell Therapies
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $21M
Investors
- 1
About Oryon Cell Therapies
Founded in 2020, Oryon Cell Therapies specializes in developing cell therapy solutions to address significant medical challenges.VC.Oryon Cell Therapies specializes in advanced regenerative medicine, focusing on cell therapy solutions designed for a range of medical conditions. Their innovative treatments enhance healing and recovery by utilizing cellular regeneration principles. Targeting chronic diseases, their therapies aim to improve patient outcomes by leveraging the body's natural healing capabilities.Oryon Cell Therapies generates revenue through partnerships with healthcare institutions and direct sales to clinics for advanced therapies. Transactions typically involve service agreements that detail the treatment costs, based on care complexity and duration. The company plans to progress its treatments toward regulatory approval while expanding into new markets, specifically targeting Europe and North America by 2027.
Who invested in Oryon Cell Therapies
1 investor across 1 round
See all investors in Oryon Cell Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 23, 2026
Amount
$21M
Investors
Questions about Oryon Cell Therapies
Who invested in Oryon Cell Therapies?
Oryon Cell Therapies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oryon Cell Therapies raised?
Oryon Cell Therapies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oryon Cell Therapies last raise money?
Oryon Cell Therapies's most recent round on record is a Series A, in Mar 2026.
What does Oryon Cell Therapies do?
Founded in 2020, Oryon Cell Therapies specializes in developing cell therapy solutions to address significant medical challenges.
Where is Oryon Cell Therapies headquartered?
Oryon Cell Therapies is headquartered in Belmont, US.
Which VCs invest in companies like Oryon Cell Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oryon Cell Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oryon Cell Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.